oleanolic acid has been researched along with 2019 Novel Coronavirus Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, R; Singh, S; Singh, SK | 1 |
| Chen, K; Gao, M; Jiang, H; Li, H; Ye, C; Yu, K | 1 |
| Aishwarya, AD; Alagarsamy, V; Kulkarni, VS; Murugesan, S; Narendhar, B; Solomon, VR; Sulthana, MT; Sundar, PS | 1 |
| Guan, M; Hu, X; Li, B; Li, S; Liu, M; Liu, S; Ning, X; Song, G; Wan, X; Wang, J | 1 |
| Lai, Y; Zhu, Y | 1 |
| Alejo-Jacuinde, G; Alolga, RN; Cai, YY; Chen, X; Chen, Y; Ding, H; Du, J; Gao, W; Guo, D; Herrera-Estrella, L; Huang, FQ; Kan, X; Li, P; Lu, X; Qi, LW; Tran, LP; Wang, X; Wei, X; Xiang, Y; Yin, X; Zhang, B | 1 |
| Gurav, NS; Gurav, SS; Prasad, RS; Prasad, SK; Shakya, A; Singh, S; Sinha, SK | 1 |
| Bahbah, EI; Nabet, MS; Negida, A | 1 |
| Pawełczyk, A; Zaprutko, L | 1 |
| Huang, B; Lai, L; Li, C; Liang, H; Liu, H; Lu, R; Sun, Q; Tan, W; Ye, F; Zhao, L | 1 |
1 review(s) available for oleanolic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pharmacological properties and derivatives of saikosaponins-a review of recent studies.
Topics: Anti-Inflammatory Agents; Antiviral Agents; COVID-19; Humans; Oleanolic Acid; Saponins; SARS-CoV-2 | 2023 |
9 other study(ies) available for oleanolic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia.
Topics: Binding Sites; COVID-19; COVID-19 Drug Treatment; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Momordica charantia; Oleanolic Acid; Plant Extracts; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Surface Plasmon Resonance | 2021 |
Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study.
Topics: Amino Acid Motifs; Binding Sites; Cell Adhesion Molecules; Computer Simulation; COVID-19; Cytokines; Epitopes; Flavanones; Glucosides; Glycosides; Humans; Lectins, C-Type; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Monosaccharides; Oleanolic Acid; Polysaccharides; Receptors, Cell Surface; Saponins; Spike Glycoprotein, Coronavirus | 2021 |
Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
Topics: Antiviral Agents; COVID-19; Molecular Docking Simulation; Molecular Dynamics Simulation; Oleanolic Acid; Plants, Medicinal; RNA, Viral; SARS-CoV-2; Sennosides; Spike Glycoprotein, Coronavirus | 2023 |
Discovery and structural optimization of 3-O-β-Chacotriosyl betulonic acid saponins as potent fusion inhibitors of Omicron virus infections.
Topics: COVID-19; HIV Fusion Inhibitors; Humans; Oleanolic Acid; Saponins; SARS-CoV-2; Virus Diseases | 2023 |
Comparative genomics of the medicinal plants Lonicera macranthoides and L. japonica provides insight into genus genome evolution and hederagenin-based saponin biosynthesis.
Topics: COVID-19; Evolution, Molecular; Genomics; Humans; Lonicera; Oleanolic Acid; Plants, Medicinal; Saponins | 2023 |
An
Topics: COVID-19; Glycoproteins; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Oleanolic Acid; Saponins; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Purposing Saikosaponins for the treatment of COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Immunologic Factors; Lymphocyte Activation; Molecular Docking Simulation; Oleanolic Acid; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Saponins; SARS-CoV-2 | 2020 |
Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives.
Topics: Antiviral Agents; Betacoronavirus; Cardiovascular Agents; Coronavirus Infections; COVID-19; Drug Repositioning; Drugs, Chinese Herbal; Humans; Oleanolic Acid; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease.
Topics: Antiviral Agents; Computational Chemistry; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; NF-E2-Related Factor 2; Oleanolic Acid; Protease Inhibitors; SARS-CoV-2; Virus Replication | 2021 |